Oramed Pharmaceuticals (ORMP) Receivables - Other (2011 - 2015)
Oramed Pharmaceuticals (ORMP) reported Receivables - Other of $33000.0 for Q2 2015, down 87.65% on a YoY basis from $267131.0 in Q2 2014, and up 1550.0% quarter-over-quarter from $2000.0 in Q1 2015.
Oramed Pharmaceuticals (ORMP) Receivables - Other (2011 - 2015) Analysis & Trends
Oramed Pharmaceuticals has reported Receivables - Other for 5 years, with the latest figure at $33000.0 in Q2 2015.
- For the quarter ending Q2 2015, Receivables - Other fell 87.65% year-over-year to $33000.0; the trailing twelve-month figure through May 2015 stood at $33000.0 (down 87.65% YoY), and the FY2014 full-year result was $78000.0, up 33.53% from the prior year.
- Receivables - Other for Q2 2015 stood at $33000.0, up from $2000.0 in the prior quarter.
- The five-year high for Receivables - Other was $330000.0 in Q3 2014, with the low at $2000.0 in Q1 2015.
- Historically, Receivables - Other has averaged $102097.5 across 5 years, with a median of $73050.0 in 2014.
- Annual changes were most pronounced in 2014 — Receivables - Other soared 468.97% — and 2015, when it plunged 97.26%.
- Oramed Pharmaceuticals' Receivables - Other stood at $63961.0 in 2011, then soared by 55.62% to $99533.0 in 2012, then tumbled by 41.73% to $58000.0 in 2013, then plunged by 53.45% to $27000.0 in 2014, then climbed by 22.22% to $33000.0 in 2015.
- The last three Receivables - Other figures came in at $33000.0 (Q2 2015), $2000.0 (Q1 2015), and $27000.0 (Q4 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2015 | 33,000.00 |
| May 31, 2015 | 33,000.00 |
| Feb 28, 2015 | 2,000.00 |
| Feb 28, 2015 | 2,000.00 |
| Nov 30, 2014 | 27,000.00 |
| Nov 30, 2014 | 27,000.00 |
| Aug 31, 2014 | 330,000.00 |
| Aug 31, 2014 | 330,000.00 |
| May 31, 2014 | 267,131.00 |
| May 31, 2014 | 267,131.00 |
| Feb 28, 2014 | 73,050.00 |
| Feb 28, 2014 | 73,050.00 |
| Aug 31, 2013 | 58,000.00 |
| Aug 31, 2013 | 58,000.00 |
| May 31, 2013 | 178,800.00 |
| May 31, 2013 | 178,800.00 |
| Feb 28, 2013 | 99,533.00 |
| Feb 28, 2013 | 99,533.00 |
| Nov 30, 2012 | 99,533.00 |
| Nov 30, 2012 | 99,533.00 |